Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Condition:   Meningococcal Infection (Healthy Volunteers) Interventions:   Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine;   Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine;   Biological: Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV);   Biologica l: Pneumoccocal Vaccine;   Biological: Measles, Mumps, and Rubella Vaccine live (MMR);   Biological: DTwP-HepB-Hib-IPV vaccine;   Biological: DTaP-IPV-Hib-HepB vaccine;   Biological: Hepatitis A vaccine;   Biological: Rotavirus vaccine;   Biological: Typhoid conjugate vaccine (T CV);   Biological: Measles vaccine;   Biological: Varicella vaccine live Sponsor:   Sanofi Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials